Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea on Wegovy is real, but it is rarely as unavoidable as people fear. Most of it is manageable with a few straightforward adjustments to when and how you eat, and for the majority of people it eases considerably within the first two to four weeks. Semaglutide slows how quickly food leaves the stomach, and that delayed gastric emptying is the direct reason meals that felt fine before can now trigger nausea — understanding that mechanism makes the practical fixes much easier to follow. As with all prescription medicines, Wegovy (semaglutide injection) requires clinical assessment before use, and a prescriber can tailor advice to your specific situation. Our prescribers discuss side effects and suitability as part of every free consultation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people starting Wegovy assume that feeling queasy means something is going wrong. It does not, and that worry can make nausea worse than it needs to be. What is happening is straightforward: semaglutide activates GLP-1 receptors in the gut and brain, slowing gastric emptying and increasing the feeling of fullness. A stomach that empties more slowly is more easily overloaded, eat the same portion you always have and the result is nausea. Once you adjust how you eat, the signal quietens for most people.
The full side-effect profile of Wegovy is worth reading before you start, because knowing what is expected stops mild symptoms feeling alarming. The NHS medicines information for semaglutide confirms that gastrointestinal effects (including nausea, vomiting, and constipation) are the most frequently reported, and typically occur around dose increases rather than throughout treatment.
That said, letting yourself believe nausea is always trivial is also unhelpful. There is a clear boundary between typical treatment-related queasiness and symptoms that require urgent attention, and this page will cover both.
The adjustments that work tend to cluster around four areas: meal size, meal composition, eating pace, and timing relative to the injection.
Keep portions small. A plate that looks modest by old standards may still be more than your stomach can comfortably process on semaglutide. Try a portion around two-thirds of what felt normal before, eat slowly, and stop before you feel full, satiety signals arrive with a slight delay. Bolting food down is one of the fastest routes to feeling sick on this medicine.
Favour low-fat, low-fibre meals when nausea is at its worst. High-fat food slows gastric emptying further on top of what semaglutide is already doing; greasy, fried or very spicy meals are frequently the trigger that people identify once they start paying attention. Plain foods (rice, toast, plain chicken, cooked vegetables) tend to sit better during the first few weeks at a new dose.
Stay upright for at least thirty minutes after eating. Lying down flattens the angle between the oesophagus and stomach, making reflux and nausea more likely. A short, gentle walk after meals also helps. Staying well hydrated throughout the day matters too, though drinking large volumes immediately before or after meals can compound the bloated feeling that leads to nausea.
Some people find that injecting Wegovy in the evening, before sleep, means the peak period of any nausea falls overnight when they notice it least. The injection can be given at any consistent time of week, so this is worth discussing with your prescriber if morning nausea is affecting your day. More detail on navigating common reactions is covered in the guide to reducing Wegovy side effects.
Ginger (as tea, capsules or even plain ginger biscuits) has reasonable evidence behind it for general nausea and is widely used alongside GLP-1 treatment, though always check with your prescriber before adding supplements. Acupressure wristbands are low-risk and some people find them useful during the first week at a new dose.
The titration schedule for Wegovy moves through several steps, each one increasing the dose of semaglutide. Most people notice that nausea reappears, or worsens briefly, each time the dose goes up, then eases again over the following one to two weeks. This is entirely predictable: your body is re-adapting to a stronger signal each time.
If nausea at a new dose remains severe after two weeks, or is disrupting sleep, eating, or daily life, contact your prescriber rather than pushing through. A slower titration (staying at the previous dose for an extra four weeks) is a recognised option and does not mean treatment has failed. The prescriber's role is precisely to make these judgements with you.
Our clinical team explains the titration pathway during the initial assessment, and aftercare is available seven days a week so you are not troubleshooting side effects alone. The full guide to Wegovy nausea has more on what to expect dose by dose, and our FAQs cover some of the questions that come up most between doses.
A note for anyone who switched from the semaglutide injection to Wegovy tablets or is considering it: the oral formulation has its own absorption mechanism and its own GI profile, so the practical advice is not identical, your prescriber can advise on what changes.
The NHS guidance on semaglutide is clear that most GI side effects are self-limiting. But some symptoms need prompt medical attention and should not be managed with ginger tea.
Seek help urgently if you develop severe, persistent stomach pain, especially pain that radiates towards your back or is accompanied by vomiting that will not settle. This combination can indicate pancreatitis, an uncommon but serious condition associated with GLP-1 medicines. The MHRA highlighted acute pancreatitis in a Drug Safety Update in January 2026 and advised patients and prescribers to be alert to this pattern of symptoms.
Other situations requiring medical review rather than self-management: vomiting so persistent that you cannot keep fluids down (dehydration risk, with implications for kidney function); signs of a serious allergic reaction such as facial swelling, rash or difficulty breathing; and any new or worsening symptoms that feel clearly out of proportion to ordinary nausea.
If you are unsure whether what you are experiencing is typical, contact our prescribing team via the aftercare line, that is what the seven-day support is for. For suspected side effects, reporting through the MHRA Yellow Card scheme contributes to ongoing safety surveillance for GLP-1 medicines. You can also find specific strategies for stopping Wegovy nausea in a dedicated guide, and broader reading on reducing semaglutide side effects across the full treatment course.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.